Over the last 7 days, the United States market has risen by 2.7%, contributing to a 21% increase over the past year, with earnings forecasted to grow by 17% annually. In this promising environment, growth companies with high insider ownership can be particularly appealing as they often signal strong confidence from those who know the business best.

Top 10 Growth Companies With High Insider Ownership In The United States

Name	Insider Ownership	Earnings Growth
Upstart Holdings (UPST)	13.9%	66.5%
Precigen (PGEN)	11.7%	59.3%
Nu Holdings (NU)	22.8%	20.2%
Karman Holdings (KRMN)	15.5%	54%
Himax Technologies (HIMX)	29.2%	70.2%
Dave (DAVE)	17.7%	22.2%
Cerebras Systems (CBRS)	11%	73.7%
Carlyle Group (CG)	27.7%	20.5%
AppLovin (APP)	23.3%	20.6%
Almonty Industries (ALM)	10.8%	46%

Let's take a closer look at a couple of our picks from the screened companies.

Power Solutions International (PSIX)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Power Solutions International, Inc. designs, engineers, manufactures, markets, and sells engines and power systems globally with a market cap of $941.53 million.

Operations: The company's revenue segments include Engineered Integrated Electrical Power Generation Systems, which generated $676.19 million.

Insider Ownership: 17.2%

Earnings Growth Forecast: 22.7% p.a.

Power Solutions International is experiencing significant leadership changes with the appointment of Richard Hu as CEO. The company faces challenges with declining sales and net income in the first half of 2026 compared to the previous year, yet it forecasts revenue growth exceeding the US market average. Despite a volatile share price, analysts anticipate a substantial increase in stock value. Trading below fair value estimates, Power Solutions offers potential upside amid its high insider ownership and strategic leadership transition.

Himax Technologies (HIMX)

Simply Wall St Growth Rating: ★★★★★★

Overview: Himax Technologies, Inc. is a fabless semiconductor company that offers display imaging processing technologies across various countries including China, Taiwan, Korea, Japan, the United States, and Mexico with a market cap of $2.55 billion.

Operations: Himax Technologies generates revenue through its provision of display imaging processing technologies across several international markets, including China, Taiwan, Korea, Japan, the United States, and Mexico.

Insider Ownership: 29.2%

Earnings Growth Forecast: 70.2% p.a.

Himax Technologies, with significant insider ownership, reported Q2 2026 earnings of US$227.37 million, up from US$214.8 million the previous year. Despite a drop in net profit margins to 4.3%, revenue growth is projected at 24.6% annually, surpassing the broader US market's expectations. The recent launch of advanced iToF Depth Decoder ICs and T2000 Color ePaper Timing Controller highlights its innovative edge in AI vision applications and dynamic display technologies, supporting robust future growth prospects despite share price volatility and an unstable dividend track record.

Nuvation Bio (NUVB)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Nuvation Bio Inc. is a clinical-stage biopharmaceutical company dedicated to developing cancer treatment product candidates, with a market cap of approximately $2.32 billion.

Operations: The company generates revenue primarily from oncology development activities, amounting to $169.90 million.

Insider Ownership: 19.3%

Earnings Growth Forecast: 67.5% p.a.

Nuvation Bio, characterized by high insider ownership, has shown remarkable revenue growth from US$4.83 million to US$31.69 million in the recent quarter. Despite a net loss of US$62.84 million, its revenue is forecasted to grow at 32.4% annually, outpacing the broader market's expectations. The company's focus on developing IBTROZI for ROS1+ NSCLC treatment underscores its innovative potential, although challenges remain with profitability and safety concerns related to hepatotoxicity and QTc prolongation risks.

Turning Ideas Into Actions

• Click this link to deep-dive into the 174 companies within our Fast Growing US Companies With High Insider Ownership screener.
• Interested In Other Possibilities? AI is about to change healthcare. These 130 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.